Whether full penetrance of D-2-HG-induced epigenetic effects in engineered cell lines can be achieved to the extent that the metabolic phenotype of clinical IDH-mutated glioma is fully mimicked, is an open question. This evidence concerns the gene IDH2 and central nervous system cancer.